Target intelligence / Profile preview

Thromboxane A synthase 1 antisense RNA (None)

Target
None
Molecular classification
Other (long non-coding RNA, lncRNA)
01

Overview

Thromboxane A synthase 1 antisense RNA is a transcript generated from the opposite DNA strand of the TBXAS1 gene region. It is categorized as a long non-coding RNA (lncRNA), and its biological function, disease associations, and therapeutic relevance are not characterized in the scientific literature. All validated therapeutic targeting refers to the enzyme thromboxane A synthase 1, not to the antisense transcript. If a therapeutic target is intended, the correct entity is the protein-coding gene TBXAS1 and its enzyme product, which is involved in the biosynthesis of thromboxane A2, a mediator of platelet aggregation and vasoconstriction[1][3][5][7][9]. The Ensembl gene ID appears to be incorrect; the canonical TBXAS1 gene is ENSG00000059377, not ENSG00000305529[7].

Other names
Novel TBXAS1 antisense RNATBXAS1-AS (hypothetical)
02

Mechanism of action

None documented for the antisense transcript. Mechanisms for TBXAS1 enzyme inhibitors include inhibition of thromboxane A2 synthesis, leading to reduced platelet aggregation and vasoconstriction[1][3][7].

03

Biological functions

Unknown; no established biological or regulatory function.By analogy to other antisense RNAs, possible roles in gene expression regulation, but not experimentally validated here.
04

Disease associations

Unknown for the antisense transcript.Thromboxane A synthase 1 itself plays roles in cardiovascular disease, stroke, and rare bone disorders, not the antisense RNA.
05

Safety considerations

None documented for the antisense transcript.Safety concerns are known for drugs targeting TBXAS1 enzyme: bleeding risk, platelet dysfunction[7][9].
06

Interacting drugs

None documented for the antisense transcript.

1 more in the full profile.

07

Biomarkers

None established for the antisense transcript.TBXAS1 protein expression or activity may be used as a biomarker in cardiovascular or bone diseases[9].

Beyond the preview

Go deeper on Thromboxane A synthase 1 antisense RNA (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thromboxane A synthase 1 antisense RNA (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call